Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Vera Therapeutics, Inc. (VERA) had Return on Investments of -13.41% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-91.10M |
|
-- |
|
-- |
|
$94.21M |
|
$-94.21M |
|
$3.11M |
|
$-91.10M |
|
$-91.10M |
|
$-91.09M |
|
$-91.09M |
|
$-91.09M |
|
$-91.09M |
|
$-94.21M |
|
$-94.54M |
|
64.23M |
|
64.23M |
|
$-1.39 |
|
$-1.39 |
|
| Balance Sheet Financials | |
$728.88M |
|
$1.37M |
|
$5.85M |
|
$734.73M |
|
$53.45M |
|
$74.84M |
|
$76.76M |
|
$130.21M |
|
$604.52M |
|
$604.52M |
|
$604.52M |
|
71.27M |
|
| Cash Flow Statement Financials | |
$-241.10M |
|
$194.29M |
|
$308.90M |
|
$92.65M |
|
$354.73M |
|
$262.08M |
|
$37.93M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.64 |
|
-- |
|
-- |
|
0.11 |
|
0.12 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-241.73M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-15.07% |
|
-15.07% |
|
-12.40% |
|
|
Return on Investments |
-13.41% |
$8.48 |
|
$-3.76 |
|
$-3.75 |
|